Tzu Chi Medical Journal
Volume 20, Issue 2 , Pages 109-111 , June 2008

Neurotoxin Versus Neuromodulation for the Treatment of Refractory Overactive Bladder Syndrome

  • Michael B. Chancellor

      Affiliations

    • Department of Urology, William Beaumont Hospital, Royal Oak, MI, USA
    • Corresponding Author InformationCorresponding author. Department of Urology, William Beaumont Hospital, 438 Medical Office Building, 3535 West 13 Mile Road, Royal Oak, MI 48073, USA
    • ,
  • Frank Costa

      Affiliations

    • Urology Institute of Pittsburgh, Pittsburgh, PA, USA
    • ,
  • Hann-Chorng Kuo

      Affiliations

    • Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan

Received 17 December 2007 ,Revised 2 January 2008 ,Accepted 2 February 2008.

References 

  1. Abrams P , Cardozo L , Fall M , et al.   The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society . Neurourol Urodyn . 2002;21:167–178
  2. Brazzelli M , Murray A , Fraser C . Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review . J Urol . 2006;175:835–841
  3. Smith CP , Radziszewski P , Borkowski A , Somogvi GT , Boone TB , Chancellor MB . Botulinum toxin A has antinociceptive effects in treating interstitial cystitis . Urology . 2004;64:871–875
  4. Apostolidis A , Dasgupta P , Fowler CJ . Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity . Eur Urol . 2006;49:644–650
  5. Schurch B , de Seze M , Denis P . Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study . J Urol . 2005;174:196–200
  6. Sahai A , Khan MS , Dasgupta P . Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial . J Urol . 2007;177:2231–2236
  7. Schmid DM , Sauermann P , Werner M . Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics . J Urol . 2006;176:177–185
  8. Ghei M , Maraj BH , Miller R . Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial . J Urol . 2005;174:1873–1877
  9. Smith CP , Nishiguchi J , O'Leary M , Yoshimura N , Chancellor MB . Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra . Urology . 2005;65:37–41
  10. Smith CP , Chancellor MB . Simplified bladder botulinumtoxin delivery technique using flexible cystoscope and 10 sites of injection . J Endourol . 2005;19:880–882
  11. Kalsi V , Popat RB , Apostolidis A . Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre . Eur Urol . 2006;49:519–527

PII: S1016-3190(08)60019-1

doi: 10.1016/S1016-3190(08)60019-1

Tzu Chi Medical Journal
Volume 20, Issue 2 , Pages 109-111 , June 2008

Article Tools